ARATOME, LLC

Medtech · Private

Array tomography imaging system with novel ligand reagents for three-dimensional neural tissue analysis at synaptic resolution

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Total capital
$585K
Federal grants
$585K
3 awards · 2015–2016
Rank in peer group#41 of 95
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
7 pending · first 2020
Rank in peer group#14 of 95

Capital timeline

20152016FEDERAL ↑EQUITY ↓Cumulative $585K$225K$135K$225K
20152016FEDERAL ↑EQUITY ↓Cumulative $585K$225K$135K$225K

Latest events

  • Federal grantHealth and Human S · Phase I · Small, high-affinity ligands for array tomography$225K
  • Federal grantHealth and Human S · Phase II · Array Tomography Visualization and Analysis Software$135K
  • Federal grantHealth and Human S · Phase I · Labeling method for high-resolution imaging of hundreds of tissue antigens$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 95 peers

Line = median

Medtech · Instrument

  • Federal grants#41 · top 43%
  • Granted patents#14 · top 15%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 8
  • PendingMolecular Detection Using Ligation AmplificationUSPTOApplication 16939921
  • GrantedMolecular Detection Using Ligation AmplificationUSPTOUS 10,781,477
  • PendingTissue Adhesive SubstratesUSPTOApplication 13827076
Show all 8 patent records
  • Molecular Detection Using Ligation AmplificationDec 3, 2020 · Application 16939921Pending
  • Molecular Detection Using Ligation AmplificationSep 22, 2020 · US 10,781,477Granted
  • Tissue Adhesive SubstratesDec 26, 2013 · Application 13827076Pending
  • Molecular Detection Using Ligation AmplificationApplication 62480107Pending
  • Molecular Detection Using Ligation AmplificationApplication 62435424Pending
  • Tissue Adhesive SubstratesApplication PCTUS2013031680Pending
  • Molecular Detection Using Ligation AmplificationApplication PCTUS2017066841Pending
  • Molecular Detection Using Ligation AmplificationApplication 62509995Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .